fda warning bpc 157 unapproved drug marketing warning letter Targets GLP-1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling BPC-157 FDA Approval Status: Is
Description
There are not a lot of long-term data: Additional studies are necessary to ensure the safety of long-term use

Animal studies also demonstrate its ability to reduce seizure threshold, alleviate depression-like behaviors, and modulate dopaminergic and serotonergic systemseven showing synergy with antidepressants and anxiolytics in preclinical models

GHK-Cu treatment is a scientifically researched and extensively studied treatment

It stimulates GH release without significantly elevating cortisol or prolactin (Raun et al., Eur J Endocrinol 1998)

Jim Moret, Nick Nolte, and even Sylvester Stallone have all used the therapy to increase their muscle performance and skin elasticity
